Femasys Inc. (NASDAQ:FEMY) Sees Significant Growth in Short Interest

Femasys Inc. (NASDAQ:FEMY) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 658,900 shares, a growth of 120.9% from the February 13th total of 298,300 shares. Based on an average daily trading volume, of 270,500 shares, the short-interest ratio is presently 2.4 days. Currently, 3.4% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and issued a $12.00 target price on shares of Femasys in a research report on Thursday.

Institutional Investors Weigh In On Femasys

Several hedge funds and other institutional investors have recently bought and sold shares of FEMY. Aljian Capital Management LLC acquired a new stake in Femasys during the third quarter worth about $27,000. XTX Topco Ltd increased its position in shares of Femasys by 123.9% during the third quarter. XTX Topco Ltd now owns 32,535 shares of the company’s stock valued at $36,000 after acquiring an additional 18,004 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Femasys by 9.2% during the third quarter. Geode Capital Management LLC now owns 206,483 shares of the company’s stock valued at $229,000 after acquiring an additional 17,473 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Femasys during the fourth quarter valued at about $25,000. Finally, Northern Trust Corp increased its position in shares of Femasys by 42.6% during the fourth quarter. Northern Trust Corp now owns 126,096 shares of the company’s stock valued at $139,000 after acquiring an additional 37,675 shares during the last quarter. 65.27% of the stock is currently owned by institutional investors and hedge funds.

Femasys Price Performance

Shares of NASDAQ FEMY traded up $0.17 during mid-day trading on Friday, reaching $1.57. The company’s stock had a trading volume of 543,053 shares, compared to its average volume of 269,067. Femasys has a 1-year low of $0.86 and a 1-year high of $2.12. The stock has a market capitalization of $35.95 million, a P/E ratio of -1.94 and a beta of -2.86. The stock has a 50-day moving average of $1.32 and a two-hundred day moving average of $1.20. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.26 and a current ratio of 3.94.

About Femasys

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.